Showing results (291-300 of 606) with videos related to
Sort By:
Pageof 61
Archives of Sexual Behavior|November 4, 2015
Event-Level Analysis of Anal Sex Roles and Sex Drug Use Among Gay and Bisexual Men in Vancouver, British Columbia, CanadaAshleigh J Rich, Nathan J Lachowsky, Zishan Cui, et al.AIDS (London, England)|March 28, 1998
Antiviral effect of double and triple drug combinations amongst HIV-infected adults: lessons from the implementation of viral load-driven antiretroviral therapyR S Hogg, S A Rhone, B Yip, et al.AIDS (London, England)|May 16, 1998
The antiviral effect of ritonavir and saquinavir in combination amongst HIV-infected adults: results from a community-based studyS A Rhone, R S Hogg, B Yip, et al.CMAJ Open|October 20, 2020
Influence of the definition of rurality on geographic differences in HIV outcomes in British Columbia: a retrospective cohort analysisDenise Jaworsky, Mona Loutfy, Michelle Lu, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|December 15, 2018
Lower Optimal Treatment Adherence Among Youth Living With HIV in a Universal Health Care Setting Where ART Is Available at No CostKalysha Closson, Alexis Palmer, Kate Salters, et al.Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1989
Kaposi's sarcoma and AIDS: a variable spectrumF A Shepherd, S Hogg-Johnson, N Fleshner, et al.Antiviral Therapy|December 3, 2003
Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refillJuan Delgado, Katherine V Heath, Benita Yip, et al.Plos One|March 11, 2011
"Dynamic range" of inferred phenotypic HIV drug resistance values in clinical practiceLuke C Swenson, Graham Pollock, Brian Wynhoven, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2004
Inability to access addiction treatment and risk of HIV infection among injection drug usersEvan Wood, Patricia Spittal, Kathy Li, et al.The Journal of Infectious Diseases|October 20, 2005
Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3Adrienne R Toulson, Richard Harrigan, Katherine Heath, et al.Pageof 61